MD Anderson Cancer Centre — Houston, Texas

MD Anderson Cancer Centre is a clinical research site located in Houston, Texas, United States 77030.

Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.

MD Anderson Cancer Centre has participated in 9 clinical trials with 5 currently active.

Therapeutic areas: Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS), Myelodysplastic Syndromes (MDS), Primary Breast Cancer ER+ve.

Sponsors: Institut de Recherches Internationales Servier, Queen Mary University of London, Lytix Biopharma AS.

Sponsor Feasibility Report

Trust Score: 77/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MD Anderson Cancer Centre?

MD Anderson Cancer Centre has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MD Anderson Cancer Centre conducted?

MD Anderson Cancer Centre has 9 clinical trials on record, with 5 currently active. Their work covers Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS), Myelodysplastic Syndromes (MDS), Primary Breast Cancer ER+ve.

Is MD Anderson Cancer Centre accredited by Crixeo Health?

MD Anderson Cancer Centre has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MD Anderson Cancer Centre?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.